|
| Press Releases |
|
 |
|
| Tuesday, December 6, 2022 |
|
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
| Thursday, June 2, 2022 |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| more info >> |
|
| Thursday, September 30, 2021 |
|
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
| Friday, July 31, 2020 |
|
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
| Friday, July 24, 2020 |
|
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
| Tuesday, October 22, 2019 |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
| Friday, June 28, 2019 |
|
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
| Friday, April 5, 2019 |
|
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| It is with deep regret that the Agency for Science, Technology and Research (A*STAR) announces the passing of Dr Sydney Brenner, Honorary Singapore Citizen, and A*STAR Senior Fellow, early this morning. more info >> |
|
| Monday, January 21, 2019 |
|
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) in tumours can be targeted to prevent and treat cancer. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Strengthening Hong Kong-Zhejiang ties 
Apr 25, 2025 21:05 HKT/SGT
|
|
|
Graphene Manufacturing Group Provides Quarterly ATM Sales Update
Apr 25, 2025 20:29 HKT/SGT
|
|
|
NEC achieves Japan's longest terrestrial wireless optical communication over 10 km
Apr 25, 2025 17:50 JST
|
|
|
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia
Apr 25, 2025 15:49 HKT/SGT
|
|
|
Edvantage Group Announces FY2025 Interim Results
Apr 25, 2025 14:40 HKT/SGT
|
|
|
Olympus Appoints New CEO
Apr 25, 2025 15:30 JST
|
|
|
TIME Interconnect Technology Limited Announces Final Results For The Year Ended 31 December 2024
Apr 25, 2025 13:17 HKT/SGT
|
|
|
DENSO Announces Year-End Financial Results
Apr 25, 2025 12:17 JST
|
|
|
Mooreast Holdings Announces Business Update
Apr 25, 2025 10:00 HKT/SGT
|
|
|
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025
Apr 24, 2025 18:43 HKT/SGT
|
|
|
DENSO and DELPHY Sign Memorandum of Understanding to Develop Data-Driven Smart Horticulture
Apr 24, 2025 18:43 JST
|
|
|
MyJCB App Wins "iF DESIGN AWARD 2025"
Apr 24, 2025 17:00 JST
|
|
|
Fujitsu launches new company 1FINITY to strengthen network products business
Apr 24, 2025 16:24 JST
|
|
|
MHIEC Completes Renovation of Core Facilities for Arita Municipal Recycle Plaza in Saga Prefecture
Apr 24, 2025 15:01 JST
|
|
|
TransNusa Increases Scheduled Flight Frequency to Singapore
Apr 24, 2025 14:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
